ArticleExperimental hematology & oncology2025
TET2 downregulation enhances the antitumor efficacy of CD19 CAR T cells in a preclinical model.
Yeongrin Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it